Found 7 matching trials
Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
PHASE3Today, the leading contender for the next influenza pandemic is H5N1, a str...
Location
GSK Investigational Site
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Children
PHASE2The present study is designed to evaluate in children (aged between 3 and 9...
Location
GSK Investigational Site
Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above
PHASE3Today, the leading contender for the next pandemic of influenza is H5N1, a ...
Location
GSK Investigational Site
Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults
PHASE3The present study is designed to assess the lot-to-lot consistency of the i...
Location
GSK Investigational Site
Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children
PHASE2The objective of the study is to evaluate the immunogenicity and safety of ...
Location
GSK Investigational Site
Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age
PHASE2The present study is designed to evaluate the immunogenicity and safety of ...
Location
GSK Investigational Site
Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults
PHASE2The present study is designed to evaluate the reactogenicity and immunogeni...
Location
GSK Investigational Site